These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women. Nasta P; Maida I; Cattelan AM; Pontali E; Angeli E; Giralda M; Verucchi G; Caputo A; Iannacone C; Puoti M; Carosi G J Womens Health (Larchmt); 2015 Feb; 24(2):159-64. PubMed ID: 25682817 [TBL] [Abstract][Full Text] [Related]
7. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Pineda JA; Caruz A; Rivero A; Neukam K; Salas I; Camacho A; Palomares JC; Mira JA; Martínez A; Roldán C; de la Torre J; Macías J Clin Infect Dis; 2010 Oct; 51(7):788-95. PubMed ID: 20804372 [TBL] [Abstract][Full Text] [Related]
8. Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy. Pineda-Tenor D; Jiménez-Sousa MA; Rallón N; Berenguer J; Soriano V; Aldámiz-Echevarria T; García-Álvarez M; Diez C; Fernández-Rodríguez A; Benito JM; Resino S AIDS Res Hum Retroviruses; 2016 Mar; 32(3):226-31. PubMed ID: 26499461 [TBL] [Abstract][Full Text] [Related]
9. TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients. Jiménez-Sousa MA; Rallón N; Berenguer J; Pineda-Tenor D; López JC; Soriano V; Guzmán-Fulgencio M; Cosín J; Retana D; García-Álvarez M; Miralles P; Benito JM; Resino S J Clin Virol; 2015 Apr; 65():62-7. PubMed ID: 25766991 [TBL] [Abstract][Full Text] [Related]
10. IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients. Jiménez-Sousa MA; Berenguer J; Rallón N; Guzmán-Fulgencio M; López JC; Soriano V; Fernández-Rodríguez A; Cosín J; Restrepo C; García-Álvarez M; Miralles P; Benito JM; Resino S J Viral Hepat; 2013 May; 20(5):358-66. PubMed ID: 23565619 [TBL] [Abstract][Full Text] [Related]
11. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; Guzmán-Fulgencio M; Aldámiz-Echevarria T; Carrero A; García-Álvarez M; Diez C; Tejerina F; Briz V; Resino S J Clin Virol; 2014 Nov; 61(3):423-9. PubMed ID: 25218243 [TBL] [Abstract][Full Text] [Related]
12. Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients. Medrano LM; Rallón N; Berenguer J; Jiménez-Sousa MA; Soriano V; Aldámiz-Echevarria T; Fernández-Rodríguez A; García M; Tejerina F; Martínez I; Benito JM; Resino S J Transl Med; 2016 Sep; 14(1):257. PubMed ID: 27590274 [TBL] [Abstract][Full Text] [Related]
13. PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study. García-Broncano P; Berenguer J; Fernández-Rodríguez A; Pineda-Tenor D; Jiménez-Sousa MÁ; García-Alvarez M; Miralles P; Aldámiz-Echevarria T; López JC; Micheloud D; Resino S J Transl Med; 2014 Aug; 12():235. PubMed ID: 25159899 [TBL] [Abstract][Full Text] [Related]
14. Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load. Neukam K; Camacho A; Caruz A; Rallón N; Torres-Cornejo A; Rockstroh JK; Macías J; Rivero A; Benito JM; López-Cortés LF; Nattermann J; Gómez-Mateos J; Soriano V; Pineda JA J Hepatol; 2012 Apr; 56(4):788-94. PubMed ID: 22173157 [TBL] [Abstract][Full Text] [Related]
15. Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients. Guzmán-Fulgencio M; Berenguer J; Pineda-Tenor D; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarria T; Carrero A; Diez C; Tejerina F; Vázquez S; Briz V; Resino S Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):385-93. PubMed ID: 25236396 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin. Liu CH; Liang CC; Liu CJ; Tseng TC; Lin CL; Yang SS; Su TH; Lin JW; Chen JH; Chen PJ; Chen DS; Kao JH Antivir Ther; 2012; 17(6):1059-67. PubMed ID: 22898703 [TBL] [Abstract][Full Text] [Related]
17. IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Fattovich G; Covolo L; Bibert S; Askarieh G; Lagging M; Clément S; Malerba G; Pasino M; Guido M; Puoti M; Gaeta GB; Santantonio T; Raimondo G; Bruno R; Bochud PY; Donato F; Negro F; Aliment Pharmacol Ther; 2011 May; 33(10):1162-72. PubMed ID: 21443535 [TBL] [Abstract][Full Text] [Related]
18. Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin. Monje-Agudo P; Castro-Iglesias A; Rivero-Juárez A; Martínez-Marcos F; Ortega-González E; Real LM; Pernas B; Merchante N; Cid P; Macías J; Merino MD; Rivero A; Mena A; Neukam K; Pineda JA; Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1929-36. PubMed ID: 26155784 [TBL] [Abstract][Full Text] [Related]
19. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387 [TBL] [Abstract][Full Text] [Related]
20. Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients. Mira JA; Valera-Bestard B; Arizcorreta-Yarza A; González-Serrano M; Torre-Cisneros J; Santos I; Vergara S; Gutiérrez-Valencia A; Girón-González JA; Macías J; López-Cortés LF; Pineda JA Antivir Ther; 2007; 12(4):523-9. PubMed ID: 17668561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]